UB Paderborn / Katalog / Suche / in CDI

Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV

Drug metabolism and disposition, 2005-04, Vol.33 (4), p.587

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy Subjects

Journal of sexual medicine, 2019-02, Vol.16 (2), p.213-222

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

British journal of clinical pharmacology, 2008-04, Vol.65 (s1), p.27-37

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir

British journal of clinical pharmacology, 2000-08, Vol.50 (2), p.99-107

2000

Link zum Volltext

Verfügbarkeit prüfen

Objective and Subjective Measures of Premature Ejaculation: How Closely Do They Correspond and How Well Are the Subjective Measures Recalled?

Journal of sexual medicine, 2020-04, Vol.17 (4), p.634-644

2020

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist—Cligosiban—in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects

Journal of sexual medicine, 2018-11, Vol.15 (11), p.1547-1557

2018

Link zum Volltext

Verfügbarkeit prüfen

Response to Letter to the Editor Regarding “Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?”

Journal of sexual medicine, 2019-11, Vol.16 (11), p.1864-1865

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

British journal of clinical pharmacology, 2008-04, Vol.65 (s1), p.38-46

2008

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

British journal of clinical pharmacology, 2008-04, Vol.65 (s1), p.5-18

2008

Link zum Volltext

Verfügbarkeit prüfen

Sildenafil citrate and blood-pressure–lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

The American journal of cardiology, 1999-03, Vol.83 (5), p.21-28

1999

Link zum Volltext

Verfügbarkeit prüfen

The karolinska cocktail for phenotyping of five human cytochrome P450 enzymes

Clinical pharmacology and therapeutics, 2003-06, Vol.73 (6), p.517-528

2003

Link zum Volltext

Verfügbarkeit prüfen

Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/ zidovudine, and ethinyloestradiol/ levonorgestrel in healthy volunteers

British journal of clinical pharmacology, 2008-04, Vol.65 (s1), p.19-26

2008

Link zum Volltext

Verfügbarkeit prüfen

Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina

Journal of the American College of Cardiology, 2000-07, Vol.36 (1), p.25-31

2000

Link zum Volltext

Verfügbarkeit prüfen

A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV‐positive subjects

British journal of clinical pharmacology, 2008-04, Vol.65 (s1), p.54-59

2008

Link zum Volltext

Verfügbarkeit prüfen

The effects of cotrimoxazole or tenofovir co‐administration on the pharmacokinetics of maraviroc in healthy volunteers

British journal of clinical pharmacology, 2008-04, Vol.65 (s1), p.47-53

2008

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality

British journal of clinical pharmacology, 2002-02, Vol.53 (s1), p.5S-12S

2002

Link zum Volltext

Verfügbarkeit prüfen

The effects of steady‐state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers

British journal of clinical pharmacology, 2002-02, Vol.53 (s1), p.37S-43S

2002

Link zum Volltext

Verfügbarkeit prüfen

Comparative human pharmacokinetics and metabolism of single‐dose oral and intravenous sildenafil

British journal of clinical pharmacology, 2002-02, Vol.53 (s1), p.13S-20S

2002

Link zum Volltext

Verfügbarkeit prüfen

The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil

British journal of clinical pharmacology, 2002-02, Vol.53 (s1), p.21S-30S

2002

Link zum Volltext

Verfügbarkeit prüfen

The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients

Kidney international, 2004-07, Vol.66 (1), p.367-374

2004

Link zum Volltext

Verfügbarkeit prüfen

P-12: Interaction between glyceryl trinitrate and sildenafil citrate (viagra®) may last less than 4 hours

American journal of hypertension, 2004-05, Vol.17 (S1), p.37A-37A

2004

Link zum Volltext

Verfügbarkeit prüfen

The effects of sildenafil on human sperm function in healthy volunteers

British journal of clinical pharmacology, 2002-02, Vol.53 (s1), p.53S-60S

2002

Link zum Volltext

Verfügbarkeit prüfen

The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil citrate

British journal of clinical pharmacology, 2002-02, Vol.53 (Suppl 1), p.21S-30S

2002

Link zum Volltext

Verfügbarkeit prüfen

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers: A Review of the Clinical Pharmacology of Maraviroc

British journal of clinical pharmacology, 2008, Vol.65, p.27-37

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV

Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy Subjects

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir

Objective and Subjective Measures of Premature Ejaculation: How Closely Do They Correspond and How Well Are the Subjective Measures Recalled?

Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist—Cligosiban—in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects

Response to Letter to the Editor Regarding “Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?”

The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX)

Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

Sildenafil citrate and blood-pressure–lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

The karolinska cocktail for phenotyping of five human cytochrome P450 enzymes

Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/ zidovudine, and ethinyloestradiol/ levonorgestrel in healthy volunteers

Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina

A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV‐positive subjects

The effects of cotrimoxazole or tenofovir co‐administration on the pharmacokinetics of maraviroc in healthy volunteers

Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality

The effects of steady‐state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers

Comparative human pharmacokinetics and metabolism of single‐dose oral and intravenous sildenafil

The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil

The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients

P-12: Interaction between glyceryl trinitrate and sildenafil citrate (viagra®) may last less than 4 hours

The effects of sildenafil on human sperm function in healthy volunteers

The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil citrate

Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers: A Review of the Clinical Pharmacology of Maraviroc

Suchergebnisse filtern